Panacea’s Huang on Biotech Market ‘Indigestion’ and Recovery
James Huang, MBA, founder of Panacea Venture, discusses evolving biotech trends and the shifting venture funding landscape.
Panacea Venture is a healthcare venture fund with global vision and reach dedicated to transforming lives through promising innovation. Spun out from Kleiner Perkins, the founding partners sought to build a global firm, investing in innovation in every geography, while bringing their unique perspectives in life sciences to benefit global company building. To date, Panacea Venture has raised three USD funds from renowned institutional funds as well as strategic investors and has investments in more than 30 private companies and several public companies.
